Phio Pharmaceuticals PHIO Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	25.17M	22.16M	20.14M	15.79M	12.81M	9.71M	12.3M	9.54M
Total Current Assets	24.73M	21.67M	19.69M	15.38M	12.45M	9.4M	12.04M	9.33M
Cash and Equivalents	24.06M	20.46M	18.02M	14.48M	11.78M	9.04M	11.31M	8.41M
Total Non-Current Assets	576k	495k	456k	414k	551k	303k	261k	211k
Total Liabilities	3.24M	2.71M	3.14M	2.26M	1.97M	2.4M	2.39M	2.33M
Total Current Liabilities	3.07M	2.57M	3.04M	2.19M	1.94M	2.4M	2.39M	2.33M
Total Non-Current Liabilities	170k	138k	104k	70k	35k	0	0	0
Common Equity	1,000	1,000	1,000	1,000	0	0	0	0
Retained Earnings	-116.9M	-119.54M	-122.07M	-125.65M	-128.38M	-131.98M	-134.53M	-137.31M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	13.4M	4.1M	15.32M	8.04M	15.74M	25.17M	12.81M	9.36M
Total Current Assets	13.11M	3.83M	15.15M	7.3M	15.16M	24.73M	12.45M	9.32M
Cash and Equivalents	12.91M	3.58M	14.88M	6.93M	14.24M	24.06M	11.78M	8.49M
Total Non-Current Assets	10.86M	1.83M	13.58M	5.75M	13.02M	21.93M	10.84M	7.73M
Total Liabilities	2.54M	2.27M	1.74M	2.29M	2.72M	3.24M	1.97M	1.63M
Total Current Liabilities	2.54M	2.27M	1.74M	1.88M	2.2M	3.07M	1.94M	1.63M
Total Non-Current Liabilities	0	0	0	411k	757k	170k	35k	0
Total Equity	10.86M	1.83M	13.58M	5.75M	13.02M	21.93M	10.84M	7.73M
Common Equity	3.53M	0	2k	1,000	1,000	1,000	0	0
Retained Earnings	0	0	-85.91M	-94.82M	-103.61M	-116.9M	-128.38M	-139.21M